Bio-Rad Laboratories (NYSE:BIO) Rating Lowered to Hold at StockNews.com
StockNews.com lowered shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a buy rating to a hold rating in a research note issued to investors on Monday morning. Other analysts have also recently issued reports about the stock. Royal Bank of Canada restated an “outperform” rating and set a $481.00 price objective on shares of […]
StockNews.com lowered shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a buy rating to a hold rating in a research note issued to investors on Monday morning. Other analysts have also recently issued reports about the stock. Royal Bank of Canada restated an “outperform” rating and set a $481.00 price objective on shares of […]
